Virus Dataset Detail

> Detail information for each sample

Dataset Information
Accession GSE162914
Status 2021/3/1
Title Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary to identify transcriptomic biomarker pathways in peripheral blood that are associated with or predict the development of death or fatal C-IRIS among patients with CM who were enrolled in the Cryptococcal Optimal ART Timing (COAT) Trial.
Samples
GSM ID Sample info Characteristics Description
GSM4965993 10006_DS-I_1 patient id:10006_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:6; baseline lfa (crag):1000; baseline hiv_rna:207202; age:34; read length:125 -
GSM4965994 10006_DS-I_4i patient id:10006_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:6; baseline lfa (crag):1000; baseline hiv_rna:207202; age:34; read length:125 -
GSM4965995 10006_DS-I_8 patient id:10006_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:6; baseline lfa (crag):1000; baseline hiv_rna:207202; age:34; read length:125 -
GSM4965996 10010_DS-I_0 patient id:10010_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:199839; age:26; read length:125 -
GSM4965997 10010_DS-I_1 patient id:10010_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:199839; age:26; read length:125 -
GSM4965998 10010_DS-I_4i patient id:10010_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:199839; age:26; read length:125 -
GSM4965999 10010_DS-I_8 patient id:10010_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:199839; age:26; read length:125 -
GSM4966000 10011_ES-I_0 patient id:10011_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:7; baseline lfa (crag):8000; baseline hiv_rna:671843; age:28; read length:50 -
GSM4966001 10011_ES-I_1 patient id:10011_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:7; baseline lfa (crag):8000; baseline hiv_rna:671843; age:28; read length:50 -
GSM4966002 10011_ES-I_4i patient id:10011_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:7; baseline lfa (crag):8000; baseline hiv_rna:671843; age:28; read length:50 -
GSM4966003 10011_ES-I_8 patient id:10011_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:7; baseline lfa (crag):8000; baseline hiv_rna:671843; age:28; read length:50 -
GSM4966004 10012_ES-N_0 patient id:10012_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:3; baseline lfa (crag):1000; baseline hiv_rna:153574; age:28; read length:125 -
GSM4966005 10012_ES-N_1 patient id:10012_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:3; baseline lfa (crag):1000; baseline hiv_rna:153574; age:28; read length:125 -
GSM4966006 10012_ES-N_4 patient id:10012_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:3; baseline lfa (crag):1000; baseline hiv_rna:153574; age:28; read length:125 -
GSM4966007 10012_ES-N_8 patient id:10012_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:3; baseline lfa (crag):1000; baseline hiv_rna:153574; age:28; read length:50 -
GSM4966008 10013_ED-I_0 patient id:10013_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:241; baseline lfa (crag):40; baseline hiv_rna:140668; age:37; read length:50 -
GSM4966009 10013_ED-I_1 patient id:10013_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:241; baseline lfa (crag):40; baseline hiv_rna:140668; age:37; read length:50 -
GSM4966010 10015_DD-N_0 patient id:10015_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:171; baseline lfa (crag):4000; baseline hiv_rna:272666; age:22; read length:50 -
GSM4966011 10015_DD-N_1 patient id:10015_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:171; baseline lfa (crag):4000; baseline hiv_rna:272666; age:22; read length:125 -
GSM4966012 10020_ED-N_0 patient id:10020_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:27; baseline lfa (crag):32000; baseline hiv_rna:247439; age:45; read length:50 -
GSM4966013 10020_ED-N_1 patient id:10020_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:27; baseline lfa (crag):32000; baseline hiv_rna:247439; age:45; read length:125 -
GSM4966014 10044_DD-N_0 patient id:10044_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:11; baseline lfa (crag):1000; baseline hiv_rna:207515; age:27; read length:125 -
GSM4966041 10080_ES-I_4i patient id:10080_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:9; baseline lfa (crag):0; baseline hiv_rna:377563; age:23; read length:50 -
GSM4966042 10080_ES-I_8 patient id:10080_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:9; baseline lfa (crag):0; baseline hiv_rna:377563; age:23; read length:50 -
GSM4966015 10044_DD-N_1 patient id:10044_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:11; baseline lfa (crag):1000; baseline hiv_rna:207515; age:27; read length:50 -
GSM4966043 10083_ES-N_0 patient id:10083_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:128; baseline lfa (crag):40; baseline hiv_rna:252349; age:33; read length:50 -
GSM4966016 10046_ES-I_0 patient id:10046_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:74383; age:26; read length:125 -
GSM4966044 10083_ES-N_1 patient id:10083_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:128; baseline lfa (crag):40; baseline hiv_rna:252349; age:33; read length:50 -
GSM4966017 10046_ES-I_1 patient id:10046_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:74383; age:26; read length:125 -
GSM4966045 10083_ES-N_4 patient id:10083_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:128; baseline lfa (crag):40; baseline hiv_rna:252349; age:33; read length:50 -
GSM4966046 10083_ES-N_8 patient id:10083_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:128; baseline lfa (crag):40; baseline hiv_rna:252349; age:33; read length:125 -
GSM4966047 10090_DD-N_0 patient id:10090_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:8; baseline lfa (crag):40; baseline hiv_rna:24554; age:50; read length:125 -
GSM4966018 10046_ES-I_4i patient id:10046_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:74383; age:26; read length:50 -
GSM4966048 10090_DD-N_1 patient id:10090_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:8; baseline lfa (crag):40; baseline hiv_rna:24554; age:50; read length:125 -
GSM4966049 10092_ED-N_0 patient id:10092_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:14; baseline lfa (crag):2000; baseline hiv_rna:281658; age:29; read length:125 -
GSM4966019 10046_ES-I_8 patient id:10046_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:74383; age:26; read length:125 -
GSM4966050 10092_ED-N_1 patient id:10092_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:14; baseline lfa (crag):2000; baseline hiv_rna:281658; age:29; read length:50 -
GSM4966059 10106_ED-I_1 patient id:10106_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:44; baseline lfa (crag):16000; baseline hiv_rna:750000; age:44; read length:50 -
GSM4966027 10058_ES-I_0 patient id:10058_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:115; baseline lfa (crag):4000; baseline hiv_rna:750000; age:38; read length:125 -
GSM4966020 10047_ES-N_0 patient id:10047_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:16; baseline lfa (crag):2000; baseline hiv_rna:356878; age:39; read length:50 -
GSM4966051 10096_DS-N_0 patient id:10096_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):4000; baseline hiv_rna:545979; age:25; read length:50 -
GSM4966052 10096_DS-N_1 patient id:10096_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):4000; baseline hiv_rna:545979; age:25; read length:50 -
GSM4966021 10047_ES-N_1 patient id:10047_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:16; baseline lfa (crag):2000; baseline hiv_rna:356878; age:39; read length:50 -
GSM4966060 10106_ED-I_4i patient id:10106_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:44; baseline lfa (crag):16000; baseline hiv_rna:750000; age:44; read length:50 -
GSM4966061 10109_DS-I_0 patient id:10109_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):16000; baseline hiv_rna:587885; age:32; read length:50 -
GSM4966028 10058_ES-I_1 patient id:10058_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:115; baseline lfa (crag):4000; baseline hiv_rna:750000; age:38; read length:125 -
GSM4966062 10109_DS-I_1 patient id:10109_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):16000; baseline hiv_rna:587885; age:32; read length:50 -
GSM4966029 10058_ES-I_4i patient id:10058_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:115; baseline lfa (crag):4000; baseline hiv_rna:750000; age:38; read length:125 -
GSM4966063 10109_DS-I_4i patient id:10109_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):16000; baseline hiv_rna:587885; age:32; read length:125 -
GSM4966064 10109_DS-I_8 patient id:10109_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):16000; baseline hiv_rna:587885; age:32; read length:50 -
GSM4966030 10058_ES-I_8 patient id:10058_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:115; baseline lfa (crag):4000; baseline hiv_rna:750000; age:38; read length:125 -
GSM4966065 10111_ED-N_0 patient id:10111_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:32; baseline lfa (crag):8000; baseline hiv_rna:555294; age:34; read length:125 -
GSM4966053 10096_DS-N_4 patient id:10096_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):4000; baseline hiv_rna:545979; age:25; read length:50 -
GSM4966066 10111_ED-N_1 patient id:10111_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:32; baseline lfa (crag):8000; baseline hiv_rna:555294; age:34; read length:125 -
GSM4966054 10096_DS-N_8 patient id:10096_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):4000; baseline hiv_rna:545979; age:25; read length:125 -
GSM4966031 10066_ES-I_0 patient id:10066_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):4000; baseline hiv_rna:207387; age:32; read length:50 -
GSM4966067 10112_DS-I_0 patient id:10112_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:78; baseline lfa (crag):1000; baseline hiv_rna:687633; age:41; read length:50 -
GSM4966068 10112_DS-I_1 patient id:10112_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:78; baseline lfa (crag):1000; baseline hiv_rna:687633; age:41; read length:50 -
GSM4966069 10112_DS-I_4i patient id:10112_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:78; baseline lfa (crag):1000; baseline hiv_rna:687633; age:41; read length:50 -
GSM4966032 10066_ES-I_4i patient id:10066_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):4000; baseline hiv_rna:207387; age:32; read length:50 -
GSM4966070 10112_DS-I_8 patient id:10112_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:78; baseline lfa (crag):1000; baseline hiv_rna:687633; age:41; read length:50 -
GSM4966033 10066_ES-I_8 patient id:10066_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:13; baseline lfa (crag):4000; baseline hiv_rna:207387; age:32; read length:50 -
GSM4966034 10072_DS-N_0 patient id:10072_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):500; baseline hiv_rna:516448; age:36; read length:50 -
GSM4966035 10072_DS-N_1 patient id:10072_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):500; baseline hiv_rna:516448; age:36; read length:50 -
GSM4966036 10072_DS-N_4 patient id:10072_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):500; baseline hiv_rna:516448; age:36; read length:125 -
GSM4966037 10075_ED-N_0 patient id:10075_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:16; baseline lfa (crag):8000; baseline hiv_rna:280539; age:37; read length:50 -
GSM4966038 10075_ED-N_1 patient id:10075_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:16; baseline lfa (crag):8000; baseline hiv_rna:280539; age:37; read length:125 -
GSM4966022 10047_ES-N_4 patient id:10047_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:16; baseline lfa (crag):2000; baseline hiv_rna:356878; age:39; read length:50 -
GSM4966071 10114_DS-N_0 patient id:10114_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:88994; age:28; read length:125 -
GSM4966055 10099_ED-I_0 patient id:10099_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:112; baseline lfa (crag):16000; baseline hiv_rna:750001; age:38; read length:125 -
GSM4966039 10080_ES-I_0 patient id:10080_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:9; baseline lfa (crag):0; baseline hiv_rna:377563; age:23; read length:50 -
GSM4966023 10051_DS-N_0 patient id:10051_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:21; baseline lfa (crag):8000; baseline hiv_rna:242722; age:33; read length:50 -
GSM4966072 10114_DS-N_1 patient id:10114_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:88994; age:28; read length:125 -
GSM4966056 10099_ED-I_1 patient id:10099_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:112; baseline lfa (crag):16000; baseline hiv_rna:750001; age:38; read length:50 -
GSM4966040 10080_ES-I_1 patient id:10080_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:9; baseline lfa (crag):0; baseline hiv_rna:377563; age:23; read length:50 -
GSM4966057 10099_ED-I_4i patient id:10099_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:112; baseline lfa (crag):16000; baseline hiv_rna:750001; age:38; read length:50 -
GSM4966073 10114_DS-N_4 patient id:10114_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:88994; age:28; read length:125 -
GSM4966024 10051_DS-N_1 patient id:10051_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:21; baseline lfa (crag):8000; baseline hiv_rna:242722; age:33; read length:125 -
GSM4966074 10114_DS-N_8 patient id:10114_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:18; baseline lfa (crag):1000; baseline hiv_rna:88994; age:28; read length:50 -
GSM4966058 10106_ED-I_0 patient id:10106_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:44; baseline lfa (crag):16000; baseline hiv_rna:750000; age:44; read length:125 -
GSM4966075 10117_ES-N_0 patient id:10117_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:381074; age:38; read length:125 -
GSM4966025 10051_DS-N_4 patient id:10051_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:21; baseline lfa (crag):8000; baseline hiv_rna:242722; age:33; read length:50 -
GSM4966076 10117_ES-N_1 patient id:10117_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:381074; age:38; read length:125 -
GSM4966026 10051_DS-N_8 patient id:10051_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:21; baseline lfa (crag):8000; baseline hiv_rna:242722; age:33; read length:125 -
GSM4966077 10117_ES-N_4 patient id:10117_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:381074; age:38; read length:125 -
GSM4966078 10120_DS-I_0 patient id:10120_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:173; baseline lfa (crag):40; baseline hiv_rna:131970; age:34; read length:50 -
GSM4966079 10120_DS-I_1 patient id:10120_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:173; baseline lfa (crag):40; baseline hiv_rna:131970; age:34; read length:125 -
GSM4966080 10120_DS-I_8 patient id:10120_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:173; baseline lfa (crag):40; baseline hiv_rna:131970; age:34; read length:50 -
GSM4966093 10158_DS-I_4i patient id:10158_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:7; baseline lfa (crag):16000; baseline hiv_rna:189143; age:38; read length:50 -
GSM4966081 10123_ES-N_0 patient id:10123_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:19; baseline lfa (crag):2100; baseline hiv_rna:220104; age:35; read length:50 -
GSM4966082 10123_ES-N_1 patient id:10123_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:19; baseline lfa (crag):2100; baseline hiv_rna:220104; age:35; read length:50 -
GSM4966099 10176_DS-I_4i patient id:10176_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:51; baseline lfa (crag):51200; baseline hiv_rna:436145; age:24; read length:125 -
GSM4966100 10176_DS-I_8 patient id:10176_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:51; baseline lfa (crag):51200; baseline hiv_rna:436145; age:24; read length:50 -
GSM4966101 10180_DD-N_0 patient id:10180_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:23; baseline lfa (crag):8000; baseline hiv_rna:559830; age:37; read length:125 -
GSM4966094 10158_DS-I_8 patient id:10158_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:7; baseline lfa (crag):16000; baseline hiv_rna:189143; age:38; read length:50 -
GSM4966102 10180_DD-N_1 patient id:10180_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:23; baseline lfa (crag):8000; baseline hiv_rna:559830; age:37; read length:125 -
GSM4966083 10123_ES-N_4 patient id:10123_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:19; baseline lfa (crag):2100; baseline hiv_rna:220104; age:35; read length:50 -
GSM4966103 10189_ED-N_0 patient id:10189_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:90; baseline lfa (crag):2000; baseline hiv_rna:750000; age:39; read length:125 -
GSM4966084 10123_ES-N_8 patient id:10123_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:19; baseline lfa (crag):2100; baseline hiv_rna:220104; age:35; read length:50 -
GSM4966104 10189_ED-N_1 patient id:10189_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:90; baseline lfa (crag):2000; baseline hiv_rna:750000; age:39; read length:50 -
GSM4966105 10191_DS-I_0 patient id:10191_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:87; baseline lfa (crag):8000; baseline hiv_rna:222576; age:40; read length:125 -
GSM4966095 10165_DD-N_0 patient id:10165_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:15; baseline lfa (crag):16000; baseline hiv_rna:307718; age:25; read length:125 -
GSM4966106 10191_DS-I_1 patient id:10191_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:87; baseline lfa (crag):8000; baseline hiv_rna:222576; age:40; read length:125 -
GSM4966085 10145_DS-N_0 patient id:10145_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):1100; baseline hiv_rna:334073; age:31; read length:50 -
GSM4966107 10191_DS-I_4i patient id:10191_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:87; baseline lfa (crag):8000; baseline hiv_rna:222576; age:40; read length:125 -
GSM4966108 10191_DS-I_8 patient id:10191_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:87; baseline lfa (crag):8000; baseline hiv_rna:222576; age:40; read length:125 -
GSM4966096 10165_DD-N_1 patient id:10165_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:15; baseline lfa (crag):16000; baseline hiv_rna:307718; age:25; read length:125 -
GSM4966086 10145_DS-N_1 patient id:10145_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):1100; baseline hiv_rna:334073; age:31; read length:50 -
GSM4966109 10201_DD-N_0 patient id:10201_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:17; baseline lfa (crag):100; baseline hiv_rna:693675; age:19; read length:125 -
GSM4966110 10201_DD-N_1 patient id:10201_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:17; baseline lfa (crag):100; baseline hiv_rna:693675; age:19; read length:50 -
GSM4966087 10145_DS-N_4 patient id:10145_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):1100; baseline hiv_rna:334073; age:31; read length:50 -
GSM4966091 10158_DS-I_0 patient id:10158_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:7; baseline lfa (crag):16000; baseline hiv_rna:189143; age:38; read length:50 -
GSM4966097 10176_DS-I_0 patient id:10176_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:51; baseline lfa (crag):51200; baseline hiv_rna:436145; age:24; read length:50 -
GSM4966111 10211_DS-I_0 patient id:10211_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):640; baseline hiv_rna:502210; age:41; read length:125 -
GSM4966088 10145_DS-N_8 patient id:10145_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):1100; baseline hiv_rna:334073; age:31; read length:50 -
GSM4966092 10158_DS-I_1 patient id:10158_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:7; baseline lfa (crag):16000; baseline hiv_rna:189143; age:38; read length:50 -
GSM4966089 10150_DD-N_0 patient id:10150_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:13; baseline lfa (crag):10000; baseline hiv_rna:750000; age:44; read length:50 -
GSM4966112 10211_DS-I_1 patient id:10211_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):640; baseline hiv_rna:502210; age:41; read length:125 -
GSM4966098 10176_DS-I_1 patient id:10176_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:51; baseline lfa (crag):51200; baseline hiv_rna:436145; age:24; read length:50 -
GSM4966113 10211_DS-I_4i patient id:10211_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):640; baseline hiv_rna:502210; age:41; read length:125 -
GSM4966090 10150_DD-N_1 patient id:10150_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:13; baseline lfa (crag):10000; baseline hiv_rna:750000; age:44; read length:50 -
GSM4966114 10211_DS-I_8 patient id:10211_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:3; baseline lfa (crag):640; baseline hiv_rna:502210; age:41; read length:125 -
GSM4966160 20057_ES-N_1 patient id:20057_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:12; baseline lfa (crag):320; baseline hiv_rna:112198; age:27; read length:125 -
GSM4966134 10234_ED-I_4i patient id:10234_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:8; baseline lfa (crag):1200; baseline hiv_rna:135050; age:26; read length:50 -
GSM4966161 20057_ES-N_8 patient id:20057_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:12; baseline lfa (crag):320; baseline hiv_rna:112198; age:27; read length:125 -
GSM4966162 20059_ES-N_0 patient id:20059_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:51; baseline lfa (crag):160; baseline hiv_rna:62508; age:28; read length:50 -
GSM4966115 10213_ES-I_0 patient id:10213_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:2; baseline lfa (crag):640; baseline hiv_rna:60053; age:29; read length:125 -
GSM4966135 10242_ED-N_0 patient id:10242_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:14; baseline lfa (crag):100; baseline hiv_rna:524805; age:41; read length:50 -
GSM4966163 20059_ES-N_1 patient id:20059_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:51; baseline lfa (crag):160; baseline hiv_rna:62508; age:28; read length:50 -
GSM4966164 20062_ES-N_0 patient id:20062_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:46; baseline lfa (crag):160; baseline hiv_rna:454232; age:35; read length:125 -
GSM4966136 10242_ED-N_1 patient id:10242_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:14; baseline lfa (crag):100; baseline hiv_rna:524805; age:41; read length:50 -
GSM4966165 20062_ES-N_1 patient id:20062_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:46; baseline lfa (crag):160; baseline hiv_rna:454232; age:35; read length:125 -
GSM4966166 20062_ES-N_8 patient id:20062_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:46; baseline lfa (crag):160; baseline hiv_rna:454232; age:35; read length:125 -
GSM4966137 10243_ED-N_0 patient id:10243_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:109; baseline lfa (crag):200; baseline hiv_rna:362590; age:42; read length:50 -
GSM4966167 20063_ES-I_0 patient id:20063_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:35; baseline lfa (crag):2560; baseline hiv_rna:30112; age:38; read length:125 -
GSM4966145 20032_ED-N_0 patient id:20032_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:10; baseline lfa (crag):1280; baseline hiv_rna:105201; age:23; read length:50 -
GSM4966138 10243_ED-N_1 patient id:10243_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:109; baseline lfa (crag):200; baseline hiv_rna:362590; age:42; read length:50 -
GSM4966116 10213_ES-I_1 patient id:10213_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:2; baseline lfa (crag):640; baseline hiv_rna:60053; age:29; read length:125 -
GSM4966168 20063_ES-I_1 patient id:20063_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:35; baseline lfa (crag):2560; baseline hiv_rna:30112; age:38; read length:50 -
GSM4966117 10213_ES-I_4i patient id:10213_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:2; baseline lfa (crag):640; baseline hiv_rna:60053; age:29; read length:125 -
GSM4966169 20063_ES-I_4i patient id:20063_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:35; baseline lfa (crag):2560; baseline hiv_rna:30112; age:38; read length:125 -
GSM4966118 10213_ES-I_8 patient id:10213_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:2; baseline lfa (crag):640; baseline hiv_rna:60053; age:29; read length:125 -
GSM4966119 10218_DS-N_0 patient id:10218_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:5; baseline lfa (crag):2100; baseline hiv_rna:138842; age:28; read length:125 -
GSM4966120 10218_DS-N_1 patient id:10218_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:5; baseline lfa (crag):2100; baseline hiv_rna:138842; age:28; read length:125 -
GSM4966121 10218_DS-N_4 patient id:10218_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:5; baseline lfa (crag):2100; baseline hiv_rna:138842; age:28; read length:125 -
GSM4966122 10218_DS-N_8 patient id:10218_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:5; baseline lfa (crag):2100; baseline hiv_rna:138842; age:28; read length:125 -
GSM4966123 10219_ED-I_0 patient id:10219_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:70; baseline lfa (crag):6400; baseline hiv_rna:358889; age:46; read length:50 -
GSM4966124 10219_ED-I_1 patient id:10219_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:70; baseline lfa (crag):6400; baseline hiv_rna:358889; age:46; read length:125 -
GSM4966125 10219_ED-I_4i patient id:10219_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:70; baseline lfa (crag):6400; baseline hiv_rna:358889; age:46; read length:125 -
GSM4966146 20032_ED-N_1 patient id:20032_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:10; baseline lfa (crag):1280; baseline hiv_rna:105201; age:23; read length:125 -
GSM4966126 10222_DD-N_0 patient id:10222_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:19; baseline lfa (crag):25600; baseline hiv_rna:321475; age:30; read length:125 -
GSM4966147 20041_DS-I_0 patient id:20041_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:37; baseline lfa (crag):320; baseline hiv_rna:750001; age:27; read length:50 -
GSM4966127 10222_DD-N_1 patient id:10222_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:19; baseline lfa (crag):25600; baseline hiv_rna:321475; age:30; read length:125 -
GSM4966148 20041_DS-I_1 patient id:20041_DS-I_1; grouping:DS-I_1; timing:I_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:37; baseline lfa (crag):320; baseline hiv_rna:750001; age:27; read length:125 -
GSM4966149 20041_DS-I_4i patient id:20041_DS-I_4i; grouping:DS-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:deferred; treatment-outcome code:DS; baseline cd4+:37; baseline lfa (crag):320; baseline hiv_rna:750001; age:27; read length:125 -
GSM4966128 10229_ES-I_0 patient id:10229_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):6400; baseline hiv_rna:70170; age:39; read length:125 -
GSM4966150 20041_DS-I_8 patient id:20041_DS-I_8; grouping:DS-I_8; timing:I_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:37; baseline lfa (crag):320; baseline hiv_rna:750001; age:27; read length:50 -
GSM4966129 10229_ES-I_1 patient id:10229_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):6400; baseline hiv_rna:70170; age:39; read length:50 -
GSM4966151 20049_DS-N_0 patient id:20049_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):160; baseline hiv_rna:104494; age:41; read length:125 -
GSM4966152 20049_DS-N_1 patient id:20049_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):160; baseline hiv_rna:104494; age:41; read length:125 -
GSM4966153 20049_DS-N_4 patient id:20049_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):160; baseline hiv_rna:104494; age:41; read length:125 -
GSM4966154 20049_DS-N_8 patient id:20049_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:17; baseline lfa (crag):160; baseline hiv_rna:104494; age:41; read length:125 -
GSM4966130 10229_ES-I_4i patient id:10229_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):6400; baseline hiv_rna:70170; age:39; read length:50 -
GSM4966155 20050_DS-N_0 patient id:20050_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:20; baseline lfa (crag):3200; baseline hiv_rna:329934; age:29; read length:50 -
GSM4966131 10229_ES-I_8 patient id:10229_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):6400; baseline hiv_rna:70170; age:39; read length:125 -
GSM4966156 20050_DS-N_1 patient id:20050_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:20; baseline lfa (crag):3200; baseline hiv_rna:329934; age:29; read length:50 -
GSM4966157 20050_DS-N_4 patient id:20050_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:20; baseline lfa (crag):3200; baseline hiv_rna:329934; age:29; read length:50 -
GSM4966132 10234_ED-I_0 patient id:10234_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:8; baseline lfa (crag):1200; baseline hiv_rna:135050; age:26; read length:125 -
GSM4966158 20050_DS-N_8 patient id:20050_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:20; baseline lfa (crag):3200; baseline hiv_rna:329934; age:29; read length:125 -
GSM4966159 20057_ES-N_0 patient id:20057_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:12; baseline lfa (crag):320; baseline hiv_rna:112198; age:27; read length:125 -
GSM4966133 10234_ED-I_1 patient id:10234_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:8; baseline lfa (crag):1200; baseline hiv_rna:135050; age:26; read length:50 -
GSM4965989 10002_ED-I_0 patient id:10002_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:750001; age:35; read length:50 -
GSM4965990 10002_ED-I_1 patient id:10002_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:750001; age:35; read length:50 -
GSM4965991 10002_ED-I_4i patient id:10002_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:13; baseline lfa (crag):32000; baseline hiv_rna:750001; age:35; read length:50 -
GSM4965992 10006_DS-I_0 patient id:10006_DS-I_0; grouping:DS-I_0; timing:I_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:6; baseline lfa (crag):1000; baseline hiv_rna:207202; age:34; read length:125 -
GSM4966139 20011_ES-N_0 patient id:20011_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:33; baseline lfa (crag):160; baseline hiv_rna:378491; age:21; read length:125 -
GSM4966140 20011_ES-N_1 patient id:20011_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:33; baseline lfa (crag):160; baseline hiv_rna:378491; age:21; read length:125 -
GSM4966170 20082_DD-N_0 patient id:20082_DD-N_0; grouping:DD-N_0; timing:N_0; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:21; baseline lfa (crag):320; baseline hiv_rna:39608; age:23; read length:125 -
GSM4966171 20082_DD-N_1 patient id:20082_DD-N_1; grouping:DD-N_1; timing:N_1; outcome:died; treatment:deferred; treatment-outcome code:DD; baseline cd4+:21; baseline lfa (crag):320; baseline hiv_rna:39608; age:23; read length:125 -
GSM4966141 20011_ES-N_4 patient id:20011_ES-N_4; grouping:ES-N_4; timing:N_4; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:33; baseline lfa (crag):160; baseline hiv_rna:378491; age:21; read length:125 -
GSM4966172 20086_DS-N_0 patient id:20086_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:48; baseline lfa (crag):2100; baseline hiv_rna:692717; age:35; read length:125 -
GSM4966173 20086_DS-N_1 patient id:20086_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:48; baseline lfa (crag):2100; baseline hiv_rna:692717; age:35; read length:125 -
GSM4966142 20023_ED-I_0 patient id:20023_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:9; baseline lfa (crag):640; baseline hiv_rna:539072; age:23; read length:50 -
GSM4966174 20086_DS-N_4 patient id:20086_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:48; baseline lfa (crag):2100; baseline hiv_rna:692717; age:35; read length:50 -
GSM4966143 20023_ED-I_1 patient id:20023_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:9; baseline lfa (crag):640; baseline hiv_rna:539072; age:23; read length:125 -
GSM4966144 20023_ED-I_4i patient id:20023_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:9; baseline lfa (crag):640; baseline hiv_rna:539072; age:23; read length:125 -
GSM4966175 20090_DS-N_0 patient id:20090_DS-N_0; grouping:DS-N_0; timing:N_0; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):320; baseline hiv_rna:130345; age:30; read length:125 -
GSM4966176 20090_DS-N_1 patient id:20090_DS-N_1; grouping:DS-N_1; timing:N_1; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):320; baseline hiv_rna:130345; age:30; read length:125 -
GSM4966177 20090_DS-N_4 patient id:20090_DS-N_4; grouping:DS-N_4; timing:N_4; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):320; baseline hiv_rna:130345; age:30; read length:125 -
GSM4966178 20090_DS-N_8 patient id:20090_DS-N_8; grouping:DS-N_8; timing:N_8; outcome:survived; treatment:deferred; treatment-outcome code:DS; baseline cd4+:10; baseline lfa (crag):320; baseline hiv_rna:130345; age:30; read length:50 -
GSM4966179 30004_ED-I_0 patient id:30004_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:61; baseline lfa (crag):8000; baseline hiv_rna:750000; age:37; read length:125 -
GSM4966197 30033_ES-I_0 patient id:30033_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:37; baseline lfa (crag):64000; baseline hiv_rna:714201; age:21; read length:50 -
GSM4966180 30004_ED-I_1 patient id:30004_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:61; baseline lfa (crag):8000; baseline hiv_rna:750000; age:37; read length:125 -
GSM4966181 30004_ED-I_4i patient id:30004_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:61; baseline lfa (crag):8000; baseline hiv_rna:750000; age:37; read length:125 -
GSM4966198 30033_ES-I_1 patient id:30033_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:37; baseline lfa (crag):64000; baseline hiv_rna:714201; age:21; read length:50 -
GSM4966182 30006_ES-I_0 patient id:30006_ES-I_0; grouping:ES-I_0; timing:I_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:12400; age:26; read length:50 -
GSM4966183 30006_ES-I_1_S40 patient id:30006_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:12400; age:26; read length:50 -
GSM4966199 30033_ES-I_4i patient id:30033_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:37; baseline lfa (crag):64000; baseline hiv_rna:714201; age:21; read length:50 -
GSM4966184 30006_ES-I_1_S55 patient id:30006_ES-I_1; grouping:ES-I_1; timing:I_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:12400; age:26; read length:50 -
GSM4966185 30006_ES-I_4i patient id:30006_ES-I_4i; grouping:ES-I_4i; timing:I_4i; outcome:survived-IRIS; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:12400; age:26; read length:50 -
GSM4966186 30006_ES-I_8 patient id:30006_ES-I_8; grouping:ES-I_8; timing:I_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:6; baseline lfa (crag):8000; baseline hiv_rna:12400; age:26; read length:50 -
GSM4966187 30012_ED-N_0 patient id:30012_ED-N_0; grouping:ED-N_0; timing:N_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:78; baseline lfa (crag):12800; baseline hiv_rna:750001; age:22; read length:50 -
GSM4966188 30012_ED-N_1 patient id:30012_ED-N_1; grouping:ED-N_1; timing:N_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:78; baseline lfa (crag):12800; baseline hiv_rna:750001; age:22; read length:125 -
GSM4966189 30015_ED-I_0 patient id:30015_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:5; baseline lfa (crag):8000; baseline hiv_rna:249000; age:34; read length:50 -
GSM4966190 30015_ED-I_1 patient id:30015_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:5; baseline lfa (crag):8000; baseline hiv_rna:249000; age:34; read length:125 -
GSM4966191 30023_ED-I_0 patient id:30023_ED-I_0; grouping:ED-I_0; timing:I_0; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:202; baseline lfa (crag):2000; baseline hiv_rna:638000; age:30; read length:50 -
GSM4966192 30023_ED-I_1 patient id:30023_ED-I_1; grouping:ED-I_1; timing:I_1; outcome:died; treatment:Early; treatment-outcome code:ED; baseline cd4+:202; baseline lfa (crag):2000; baseline hiv_rna:638000; age:30; read length:50 -
GSM4966193 30023_ED-I_4i patient id:30023_ED-I_4i; grouping:ED-I_4i; timing:I_4i; outcome:died-IRIS; treatment:Early; treatment-outcome code:ED; baseline cd4+:202; baseline lfa (crag):2000; baseline hiv_rna:638000; age:30; read length:125 -
GSM4966194 30028_ES-N_0 patient id:30028_ES-N_0; grouping:ES-N_0; timing:N_0; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:87; baseline lfa (crag):500; baseline hiv_rna:763300; age:34; read length:50 -
GSM4966195 30028_ES-N_1 patient id:30028_ES-N_1; grouping:ES-N_1; timing:N_1; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:87; baseline lfa (crag):500; baseline hiv_rna:763300; age:34; read length:50 -
GSM4966196 30028_ES-N_8 patient id:30028_ES-N_8; grouping:ES-N_8; timing:N_8; outcome:survived; treatment:Early; treatment-outcome code:ES; baseline cd4+:87; baseline lfa (crag):500; baseline hiv_rna:763300; age:34; read length:50 -
Platform GPL16791  : Illumina HiSeq 2500 (Homo sapiens)
Literature 33863324  
Download Download xCell Data  Download Expression Analysis Data  
xCell Plot
* p<0.05 ** p<0.01